✦ LIBER ✦

Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients

✍ Scribed by Ruriko Tanaka; Shinya Kimura; Eishi Ashihara; Mariko Yoshimura; Naoto Takahashi; Hisashi Wakita; Kuniaki Itoh; Kaichi Nishiwaki; Kenshi Suzuki; Rina Nagao; Hisayuki Yao; Yoshihiro Hayashi; Sakiko Satake; Hideyo Hirai; Ken-ichi Sawada; Oliver G. Ottmann; Junia V. Melo; Taira Maekawa

Book ID: 116335735
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 558 KB
Volume: 312
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2011.08.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteristics of BCR–ABL kinase domain

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

✍ YaZhen Qin; ShanShan Chen; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; LingDi L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 116 KB

Mutations in the ABL kinase domain pre-e

Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment

✍ Catherine Roche-Lestienne; Claude Preudhomme 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Denaturing-HPLC-Based Assay for Detectio

Denaturing-HPLC-Based Assay for Detection of ABL Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib

✍ Soverini, S. 📂 Article 📅 2004 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 238 KB

[Methods in Molecular Biology] Hematolog

[Methods in Molecular Biology] Hematological Malignancies Volume 999 || Detection of BCR-ABL1 Kinase Domain Mutations Causing Imatinib Resistance in Chronic Myelogenous Leukemia

✍ Czader, Magdalena 📂 Article 📅 2013 🏛 Humana Press ⚖ 367 KB

Mutations of the BCR-ABL-kinase domain o

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib

✍ Sherbenou, D W; Wong, M J; Humayun, A; McGreevey, L S; Harrell, P; Yang, R; Maur 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

In vitro Activity of Bcr-Abl Inhibitors

In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants

✍ O'Hare, T. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 846 KB